How does cannabis interact with other medications for fibromyalgia?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

For patients exploring cannabis as part of their fibromyalgia treatment, it’s crucial to consider possible cannabis drug interactions. Since many individuals with fibromyalgia take prescription medications ranging from antidepressants to painkillers, understanding how cannabis may interact with these drugs is key to avoiding safety concerns.

Cannabis, particularly its cannabinoids THC and CBD, is processed by the liver using the same enzymes as many pharmaceutical drugs. This can lead to medication conflicts by either intensifying or weakening the effects of the medication. Open dialogue with a healthcare provider ensures a safe and well-rounded treatment plan.

Potential cannabis drug interactions to monitor

Here are some of the most common cannabis drug interactions relevant to fibromyalgia care:

Antidepressants

Cannabis may increase or reduce the effectiveness of SSRIs or SNRIs, potentially affecting mood stability or leading to excessive drowsiness.

Pain Medications

Cannabis and opioids both affect pain pathways. When combined, they can amplify sedation, increasing the risk of overdose without proper monitoring.

Muscle Relaxants

Taken together, cannabis and muscle relaxants can lead to dizziness, fatigue, or impaired motor function.

Anti-Seizure Medications

CBD in particular can alter levels of medications like clobazam, making dosage adjustments necessary.

Blood Pressure or Heart Medications

There is a risk of altered blood pressure or heart rate when cannabis is combined with cardiovascular drugs.

To avoid medication conflicts and other safety concerns, it’s essential to keep your medical team informed. With the right guidance, cannabis can be integrated safely into a broader fibromyalgia treatment plan.

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.